Related Experiment Video

Updated: Oct 7, 2026

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

Management of cytomegalovirus infection and disease after solid-organ transplantation

W van der Bij1, R Speich

  • 1Department of Clinical Immunology, University Hospital, Groningen, The Netherlands. w.van.der.bij@int.azg.nl

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|June 5, 2001
PubMed

Insights

Cytomegalovirus (CMV) infection poses significant risks after solid-organ transplantation, leading to disease, secondary infections, and graft injury. Advances in risk factor identification, rapid detection, and antiviral therapies are improving prevention and treatment outcomes.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Transplantation Medicine

Background:

  • Cytomegalovirus (CMV) is a significant cause of morbidity and mortality in solid-organ transplant recipients.
  • CMV infection can lead to severe clinical illnesses (CMV disease), opportunistic superinfections, and contribute to chronic rejection of the transplanted organ.

Purpose of the Study:

  • To review the progress in understanding and managing Cytomegalovirus (CMV) infection in solid-organ transplant recipients.
  • To highlight advancements in identifying CMV risk factors, diagnostic methods, and therapeutic strategies.

Main Methods:

  • Review of current literature on CMV in solid-organ transplantation.
  • Discussion of risk factor elucidation, diagnostic techniques, and antiviral treatments.

Main Results:

  • Significant progress has been made in identifying risk factors associated with CMV disease.
  • Rapid detection methods for CMV in clinical specimens are now available.
  • Antiviral chemotherapy and immunoglobulin have shown efficacy in preventing and treating CMV disease.

Conclusions:

  • Effective strategies for preventing and treating CMV disease post-transplant have been developed.
  • Continued research and clinical application of these advancements are crucial for improving patient outcomes.

More Related Videos

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System10:24

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Published on: October 5, 2015

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...